Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Total Current Liabilities (2016 - 2020)

Historic Total Current Liabilities for Monopar Therapeutics (MNPR) over the last 5 years, with Q3 2020 value amounting to $609840.0.

  • Monopar Therapeutics' Total Current Liabilities rose 2608.7% to $609840.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $609840.0, marking a year-over-year increase of 2608.7%. This contributed to the annual value of $724165.0 for FY2019, which is 8124.47% up from last year.
  • Latest data reveals that Monopar Therapeutics reported Total Current Liabilities of $609840.0 as of Q3 2020, which was up 2608.7% from $573127.0 recorded in Q2 2020.
  • Monopar Therapeutics' 5-year Total Current Liabilities high stood at $724165.0 for Q4 2019, and its period low was $64510.0 during Q4 2016.
  • Its 5-year average for Total Current Liabilities is $429542.8, with a median of $443520.0 in 2020.
  • In the last 5 years, Monopar Therapeutics' Total Current Liabilities skyrocketed by 38343.98% in 2017 and then tumbled by 2352.92% in 2020.
  • Monopar Therapeutics' Total Current Liabilities (Quarter) stood at $64510.0 in 2016, then skyrocketed by 383.44% to $311867.0 in 2017, then grew by 28.12% to $399551.0 in 2018, then surged by 81.24% to $724165.0 in 2019, then fell by 15.79% to $609840.0 in 2020.
  • Its Total Current Liabilities stands at $609840.0 for Q3 2020, versus $573127.0 for Q2 2020 and $443520.0 for Q1 2020.